Research and Development

Two stakeholder workshops which could shape NICE's future direction are to be held next week. Professor Sir Ian Kennedy has …

AstraZeneca has been lifted by clinical results indicating its antiplatelet drug Brilinta outperformed Sanofi-Aventis/Bristol-Myers Squibb’s Plavix – currently the world’s …

The first step towards producing a European prototype of a swine flu vaccine has been achieved by the UK's Health …

GlaxoSmithKline says a new study shows its cervical cancer vaccine Cervarix induces a higher immune response compared to rival Gardasil. …

UK contract research organisation Cmed Research has bolstered its ability to carry out adaptive clinical trials on behalf of clients …

Pharma companies will soon have to start collaborating with companies outside the healthcare sector.The global economic situation will make this …

Servier, France's largest privately-owned pharma company, has signed a new three-year drug discovery deal with Vernalis focused on oncology. UK …

NICE has rejected Nexavar as a treatment for liver cancer, saying it is not a cost-effective use of NHS resources. …

Novo Nordisk is preparing Victoza for a summer launch into its first European markets, including the UK, after it was …

The NHS could be the 'jewel in the crown' of UK medical research, if it would only assist in clinical …

Bayer Schering is to start phase III trials of its new contraceptive patch and anticipates submitting the product for regulatory …

A US company offering institutional review board services to sponsors of clinical trials has been forced to close its doors …

Action Pharma’s Torben Jung Laursen explores the new challenges facing pharma-biotech partnering as a result of the economic downturn.In today’s …

Roche's blockbuster Avastin has failed to show success in treating early-stage colon cancer. A phase III trial found Avastin (bevacizumab) …

Sanofi-Aventis has suspended development of four late-stage drugs and ten other projects following an R&D review. The decision was announced …